Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study.
2008
Abstract
Treatment with fumarate reduced number of new active lesions in magnetic resonance and number of relapses. Treatment was safe and generally well tolerated.
The results entitle to continue in long-term phase III study in large patient population.